28 Million Americans are currently fighting cancer. However, with ongoing cancer research and new combination treatments, patients have a better understanding of what to expect from various types of cancer. Immunotherapy has been slower to demonstrate progress in gynecologic cancers than in several other solid tumors, experts say. “We have not increased the number of…
Details
Head and neck cancer linked to HPV (human papilomavirus infection) is becoming increasingly common. A new form of treatment is in development, involving low-dose radiation. Check out a recent release covering this treatment, from Memorial Sloan Kettering Cancer Center, below. The number of head and neck cancers related to human papillomavirus (HPV) infection has surged…
Details
Moffitt Cancer Center is a proud supporter and corporate partner of C3 For Change. The center’s health informatics subsidiary, M2Gen, recently received an equity investment by Hearst, a leader in healthcare technology. Check out a portion of the press release, below. NEW YORK and TAMPA, FLA. — Hearst, a market leader in healthcare technology, announced…
Details
The month of September is dedicated to raising awareness for Pediatric Cancer. Did you know that only 4% of funds raised for cancer research benefit pediatric cancer research? Most children and teens with cancer are treated at large pediatric cancer centers. Pediatric cancer treatment is usually offered to children from birth to age 18 or…
Details
The human papillomavirus (HPV) is linked directly to one of the most deadly forms of cancer, cervical cancer. However, a new study published earlier this week in The Lancet reveals that researchers, including those from Moffitt Cancer Center, have found great success in HPV prevention through vaccination. TAMPA, Fla. – Cervical cancer is the second…
Details
The FB Marine Group / AutoNation Cure Bowl / Salt Eliminator Offshore Race Team recently competed in the 2017 Sarasota Powerboat Grand Prix, snagging a 2nd place finish in their 41′ MTI catamaran. Check out a gallery from the race, below! This is the 3rd season the AutoNation Cure Bowl graphics have been showcased by…
Details
Did you know that every third Tuesday of September is Take a Loved One for a Checkup Day? Created as a reminder to help friends and family visit with a health care professional, it’s definitely a date to mark on the calendar. Read more about the day, below. According to the US Department of Health…
Details
According to the results of a study recently published in JAMA Dermatology, patient age may be a contributing factor in determining SLNB recommendations in cases of thin melanomas. “Patient age was shown to be an important discriminant of nodal positivity among patients with mitogenic tumors 0.50 to 0.75 mm and 0.76 to 1.0 mm and…
Details
Collaborating on a project called the Future of Radiation Therapy—aimed at revolutionizing radiation therapy, Moffitt Cancer Center and Cvergenx are providing a personalized radiation treatment plan based on the patients genetic framework! Read on, below, for more information! Moffitt’s Radiation Oncology Department will utilize Cvergenx’s Genomic-Adjusted Radiation Dose (GARD) model. GARD is the first validated…
Details